Unfortunately, Internet Explorer is an outdated browser and we do not currently support it. To have the best browsing experience, please upgrade to Google Chrome.
Upgrade27 March 2023
One Health Group plc
("One Health" or the "Company")
Exercise of options and Total Voting Rights
One Health (AQSE: OHGR), a provider of NHS-funded medical procedures, announces that it has issued 476,760 new ordinary shares of 0.5 pence each in the Company (the "New Ordinary Shares") pursuant to the exercise of options under the One Health Group Share Option Plan.
An application has been made for the New Ordinary Shares to be admitted to trading on the Apex segment of the AQSE Growth Market (“Admission”). It is expected that Admission will become effective at 8.00 a.m. on or around 30th March 2023.
Following Admission, the total number of ordinary shares and voting rights in the Company will be 10,510,093. The Company does not hold any shares in treasury.
The above figure of 10,510,093 may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA's Disclosure and Transparency Rules.
The directors of One Health accept responsibility for this announcement.
Ends
Enquiries:
One Health Group plc
Via Square1 Consulting
Oberon Capital (AQSE Corporate Adviser and Broker)
Nick Lovering, Mike Seabrook
020 3179 5300
Square 1 Consulting
David Bick
020 7929 5599
One Health Group utilises specialist consultants and healthcare managers working together to provide the best possible diagnosis and treatment for our patients.
